![Robert Scott](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Scott
Directeur Technique/Scientifique/R&D chez
ABIONYX PHARMA SA
Fortune : 74 506 $ au 30/09/2026
Profil
Dr. Robert A. Scott, MD, is an Independent Director at Arcutis Biotherapeutics, Inc., a Chief Medical Officer, Head-Research & Development at ABIONYX Pharma SA and an Independent Director at Confo Therapeutics NV.
He is on the Board of Directors at Arcutis Biotherapeutics, Inc., Redx Pharma Ltd., Confo Therapeutics NV, Variant Bio, Inc., Draupnir Bio ApS and OncoSpherix, Inc. Dr. Scott was previously employed as a Lead Independent Director by Windtree Therapeutics, Inc., a Chief Medical Officer & Head-Development by AbbVie SA, a VP & Head-Global Cardiovascular Development by Amgen, Inc., a Chief Medical Officer by Cerenis Therapeutics, Inc., and a Principal by Pfizer Inc. He also served on the board at ArisGlobal LLC, AtheroGenics, Inc. and Transcelerate Biopharma, Inc. He received his undergraduate degree from the University of Cape Town and a doctorate degree from the University of Cape Town.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/10/2026 | 2 819 ( 0% ) | 74 506 $ | 30/09/2026 |
Postes actifs de Robert Scott
| Sociétés | Poste | Début |
|---|---|---|
| ABIONYX PHARMA SA | Directeur Technique/Scientifique/R&D | 08/01/2024 |
| REDX PHARMA LIMITED | Directeur/Membre du Conseil | 27/01/2022 |
| ARCUTIS BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | 23/10/2026 |
Confo Therapeutics NV
 Confo Therapeutics NV Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur/Membre du Conseil | 10/06/2020 |
Draupnir Bio ApS
 Draupnir Bio ApS BiotechnologyHealth Technology Operates as a biotechnology company that develops oral and small molecule degraders of extracellular diseases | Directeur/Membre du Conseil | - |
OncoSpherix, Inc.
 OncoSpherix, Inc. Miscellaneous Commercial ServicesCommercial Services Develops innovative cancer therapeutics through oncology research & drug development programs | Directeur/Membre du Conseil | - |
Variant Bio, Inc.
 Variant Bio, Inc. BiotechnologyHealth Technology Develops therapeutics for human generic diversity | Directeur/Membre du Conseil | 01/05/2020 |
Anciens postes connus de Robert Scott
| Sociétés | Poste | Fin |
|---|---|---|
ArisGlobal LLC
 ArisGlobal LLC Packaged SoftwareTechnology Services Provides software services for life sciences industry | Directeur/Membre du Conseil | 01/10/2024 |
| WINDTREE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/09/2024 |
| ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Robert Scott
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
72
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Windtree Therapeutics, Inc.
 Windtree Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapeutics to address significant unmet medical needs in acute care markets | Health Technology |
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Health Technology |
University of Cape Town
 University of Cape Town Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ABIONYX Pharma SA
 ABIONYX Pharma SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel HDL therapies for the treatment of cardiovascular and metabolic diseases | Health Technology |
Cerenis Therapeutics, Inc.
 Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs | Health Technology |
ArisGlobal LLC
ArisGlobal LLC Packaged SoftwareTechnology Services Provides software services for life sciences industry | Technology Services |
Redx Pharma Plc
 Redx Pharma Plc BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on developing novel, small molecule and targeted medicines for fibrotic disease | Health Technology |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Health Technology |
Confo Therapeutics NV
Confo Therapeutics NV Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
AbbVie SA | |
Arcutis Biotherapeutics, Inc.
 Arcutis Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immunodermatology drug development company | Health Technology |
Variant Bio, Inc.
Variant Bio, Inc. BiotechnologyHealth Technology Develops therapeutics for human generic diversity | Health Technology |
Draupnir Bio ApS
Draupnir Bio ApS BiotechnologyHealth Technology Operates as a biotechnology company that develops oral and small molecule degraders of extracellular diseases | Health Technology |
OncoSpherix, Inc.
OncoSpherix, Inc. Miscellaneous Commercial ServicesCommercial Services Develops innovative cancer therapeutics through oncology research & drug development programs | Commercial Services |
